AstraZeneca's first DTC for its lupus med Saphnelo literally highlights the individual nature of the disease's symptoms.
AstraZeneca bows first ad campaign for lupus med Saphnelo, highlights patients' personal experiences
Lupus isn’t fair — and AstraZeneca’s debut direct-to-consumer ad campaign for Saphnelo wants to let patients know that it understands. And that it’s here to disrupt …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
